Do you have a great research-based idea in Health Tech, Bioindustrials or Therapeutics? Are you ready to bring your research out of the lab and into the economy?
BioInnovation Institute (BII) offers life science researcher and entrepreneurs access to a vibrant life science community with 3500 square meter of advanced lab and office facilities, business acceleration programs, commercial support, funding opportunities and access to high-level mentoring and networks. We embrace every stage of a life science start-up, so whether the idea of pursuing entrepreneurship has briefly crossed your mind, or you already have a full business plan for your project, there is a place for you at BII.
We are a Novo Nordisk Foundation Initiative, and we work for the benefit of human welfare and society.
BioInnovation Institute (BII) offers life science researcher and entrepreneurs access to a vibrant life science community with 3500 square meter of advanced lab and office facilities, business acceleration programs, commercial support, funding opportunities and access to high-level mentoring and networks. We embrace every stage of a life science start-up, so whether the idea of pursuing entrepreneurship has briefly crossed your mind, or you already have a full business plan for your project, there is a place for you at BII.
We are a Novo Nordisk Foundation Initiative, and we work for the benefit of human welfare and society.
Location: Denmark
Employees: 51-200
Total raised: $29.82M
Founded date: 2018
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.03.2026 | - | $584.75K | - |
| 03.02.2026 | - | $29.24M | - |
Mentions in press and media 21
| Date | Title | Description |
| 04.06.2026 | Cambridge Enterprise builds London launchpad for next generation of deeptech founders | A new Cambridge Enterprise Initiative called Leaps is launching today to embed Cambridge-based companies in complementary ecosystems, giving selected founders access to new markets, talent and investment in key geographical hotspots to enab... |
| 13.05.2026 | BioInnovation Institute launches AI Lab with €7M from Danish Industry Foundation | BioInnovation Institute (BII) is launching AI Lab, a new innovation platform designed to support the commercialisation of artificial intelligence research and accelerate the development of early-stage AI startups in Denmark. The initiative ... |
| 07.04.2026 | HexemBio Raises $10.4M in Seed Funding | HexemBio, a NYC-based biotechnology company developing blood stem cell rejuvenation therapies, raised $10.4M in Seed funding. The round was led by Draper Associates with participation from SOSV, Seraphim, and other investors. The company in... |
| 10.03.2026 | BioInnovation Institute adds 11 startups to Venture Lab cohort | BioInnovation Institute (BII), a Copenhagen-based non-profit innovation hub established by the Novo Nordisk Foundation, is supporting 11 companies through its 12-month Venture Lab programme. Each company receives €500,000 in convertible loa... |
| 03.03.2026 | BioInnovation Institute backs five startups with €1.3M in follow-on funding | BioInnovation Institute (BII), an initiative of the Novo Nordisk Foundation, has awarded an additional €1.3 million in follow-on funding to five portfolio startups, bringing total support per company to up to €1.8 million. The funding is in... |
| 02.03.2026 | Five Danish startups enter BII’s Venture House 8 cohort with €1.3 million follow-on backing | BioInnovation Institute (BII), a Novo Nordisk Foundation Initiative, has provided an additional €1.3 million in follow-on funding to five portfolio startups – Synuca Therapeutics, Gefjon Pharma, MicroMiner, DARERL and Diasense – bringing th... |
| 09.02.2026 | Novo Nordisk Foundation: BioInnovation Institute Launches Upscalator With Up To €25 Million | The Novo Nordisk Foundation has allocated up to €25 million to launch a new initiative called Upscalator, designed to help early-stage Danish and European biosolutions startups scale their technologies toward market readiness and support th... |
| 03.02.2026 | BII secures €25 million in Novo Nordisk Foundation funding to target early-stage European biosolutions startups | The Novo Nordisk Foundation has allocated up to €25 million for the BioInnovation Institute (BII) to launch a new initiative, ‘Upscalator’, to support Danish and European early-stage startups with facilities, services, and expertise to supp... |
| 16.01.2026 | Novo Nordisk Foundation Fuels €736 Million European Innovation Drive | Novo Nordisk Foundation injects €736 million into BioInnovation Institute (BII), powering a decade-long drive to elevate European innovation. This landmark funding, spanning 2026-2035, targets a critical gap: translating world-class researc... |
| 15.01.2026 | Novo Nordisk Foundation backs BioInnovation Institute with €736M to scale life sciences and deeptech innovation | The Novo Nordisk Foundation has allocated up to €736 million (DKK 5.5 billion) to BioInnovation Institute (BII), a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its activiti... |
Show more